What Is the Life Expectancy With Relapsing Polychondritis?

The prognosis and life expectancy for someone with relapsing polychondritis (RP) vary widely and depend heavily on which organs are affected and how well the disease responds to treatment. There is no single “life expectancy” for RP. For many people, especially those whose inflammation is caught early and controlled, a normal or near-normal lifespan is possible. However, because RP can affect critical structures like the airways and blood vessels, it can lead to serious, life-threatening complications. Understanding your specific risks and actively monitoring for hidden damage are the best ways to protect your long-term health.

Overall Survival and Modern Outcomes

Modern medicine has significantly improved the outlook for people with RP, though estimates come from specific observational cohorts rather than individual forecasts. Recent studies show that 5-year survival rates range from 84% to 95%, and 10-year survival rates range from 75% to 91% ^[1][2]. In a recent Japanese survey, the observed mortality rate dropped from 9.2% in 2009 to just 1.6% in 2019, a period that coincided with the increased use of targeted biologic therapies, though the study design cannot definitively prove that biologics caused the improvement ^[3].

Despite these encouraging trends, RP remains a serious disease. A UK population study found the overall mortality rate for people with RP was roughly twice that of the general population ^[4]. The most frequent causes of death in these cohorts are related to respiratory failure, cardiovascular complications, and associated cancers or blood disorders ^[4][1].

Factors Associated With Prognosis

Certain features have been associated with a higher risk of severe disease in observational studies. It is important to remember that these are statistical associations for groups of patients, not individual predictions:

• Airway involvement at onset: People whose first symptoms involve the respiratory tract often have more aggressive disease than those whose initial symptoms are limited to the ears ^[5].
• Male sex and older age: Being male or developing the disease at an older age has been linked to higher mortality risks in certain cohorts ^[1][6].
• High inflammatory markers: Elevated levels of inflammation in the blood (like CRP) are associated with more frequent relapses, though CRP is non-specific and can also be elevated by common infections ^[7].
• Associated blood disorders: The presence of a hematologic (blood) condition, such as myelodysplastic syndrome, is associated with a more difficult clinical course and higher mortality ^[1].

Major Complications and Organ Damage

RP does not just cause temporary pain; repeated episodes of inflammation can lead to irreversible damage to cartilage and other tissues ^[8][9]. The long-term outlook depends on preventing damage in several key areas:

The Airways and Lungs

Respiratory involvement is a highly dangerous complication of RP and a leading cause of death ^[10]. Inflammation of the cartilage in the windpipe (trachea) and breathing tubes (bronchi) can cause the airways to narrow or become floppy, a condition called tracheobronchomalacia ^[11]. This can lead to severe shortness of breath, recurrent respiratory infections, and respiratory failure ^[12]. Because early airway symptoms (like a persistent cough or wheezing) are often misdiagnosed as asthma, diagnosis and appropriate evaluation can be dangerously delayed ^[13][14].

The Heart and Blood Vessels

Cardiovascular complications are another major driver of mortality ^[1]. Inflammation can attack the aorta (the body’s main artery), leading to an aneurysm (a dangerous bulging of the blood vessel) or an aortic dissection or rupture (a tearing or bursting of the artery wall), which are frequent causes of death ^[15][16]. Aortic involvement can be completely asymptomatic in its early stages ^[15].

EMERGENCY WARNING: Seek immediate emergency medical care if you experience severe or rapidly worsening shortness of breath, noisy breathing (stridor), blue lips, inability to speak normally, fainting, or sudden severe chest or back pain. These can be signs of life-threatening airway collapse or a sudden vascular emergency.

Hearing, Vision, and Cartilage Deformities

While less likely to be fatal, damage to the sensory organs and structural cartilage heavily impacts long-term quality of life. Repeated inflammation can cause the cartilage of the nose or ears to collapse ^[17][8]. Furthermore, inner ear inflammation can cause hearing impairment—in a patient survey, roughly a third reported hearing loss, some of which may be permanent ^[8]. Eye inflammation, such as scleritis or uveitis (inflammation of the white of the eye or inner eye structures), can threaten vision if left untreated ^[18]. Seek prompt ophthalmic assessment for painful red eyes, light sensitivity, or new vision changes.

The VEXAS Syndrome Overlap

In recent years, researchers discovered that a subset of people diagnosed with RP actually have VEXAS syndrome ^[19]. VEXAS is caused by an acquired (somatic) mutation in the UBA1 gene—meaning it occurs in blood-forming cells later in life and is not a genetic condition inherited by children. It predominantly affects men over the age of 50, though exceptions exist ^[20].

Patients with VEXAS-associated RP typically face a more severe clinical course; one specific study observed a mortality rate of 23% in the VEXAS group compared to 4% in those with standard RP ^[19]. Warning features for VEXAS include unexplained anemia (specifically with unusually large red blood cells, called macrocytosis), low blood platelets, blood clots, fevers, and skin rashes ^[20][21]. If you have compatible systemic inflammation, your doctor may consider specialized genetic testing.

Quality of Life and Treatment Toxicity

Prognosis isn’t just about survival—it is also about how you live. Many patients report that RP deeply affects their ability to work, personal relationships, and mental health, primarily due to severe fatigue and chronic pain ^[22][23].

Treatments required to keep RP in check carry their own long-term risks. High doses of glucocorticoids (steroids like prednisone) are often necessary, but prolonged use can lead to severe osteoporosis (bone thinning), diabetes, high blood pressure, and a high risk of serious infections ^[24][25]. Never stop taking glucocorticoids abruptly, as this can be dangerously harmful; tapers must be closely supervised.

To protect your long-term health, your rheumatologist may try to transition you to steroid-sparing medications, such as conventional immunosuppressants or targeted biologic drugs. Evidence for these drugs in RP is largely observational, but they may help control disease and reduce the burden of steroid toxicity ^[26][27].

Protecting Your Health Through Monitoring

Because complications can develop silently, proactive specialist assessment is crucial. However, there is no universally accepted surveillance schedule. Testing must be individualized based on your symptoms, physical exam, and specific organ involvement ^[28]. Assessments considered by your doctor may include:

• Dynamic chest CT scans and pulmonary function tests (PFTs) to check for hidden airway narrowing. Note that PFTs alone can miss airway disease, and repeated CTs carry radiation risks ^[29].
• Echocardiograms or advanced vascular imaging (like CT or MR angiography). Standard echocardiograms do not reliably evaluate the entire aorta, so additional imaging may be needed if vascular involvement is suspected ^[15].

Building a multidisciplinary care team—which may include rheumatology, pulmonology, otolaryngology (ENT), cardiology, or ophthalmology—helps catch complications early and secure the best possible long-term outcome ^[14].